180 related articles for article (PubMed ID: 22808921)
21. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young.
Vesterhus M; Haldorsen IS; Raeder H; Molven A; Njølstad PR
J Clin Endocrinol Metab; 2008 Sep; 93(9):3505-9. PubMed ID: 18593771
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
Mughal SA; Park R; Nowak N; Gloyn AL; Karpe F; Matile H; Malecki MT; McCarthy MI; Stoffel M; Owen KR
Diabet Med; 2013 Feb; 30(2):246-50. PubMed ID: 23157689
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic stone protein/regenerating protein (PSP/reg): a novel secreted protein up-regulated in type 2 diabetes mellitus.
Yang J; Li L; Raptis D; Li X; Li F; Chen B; He J; Graf R; Sun Z
Endocrine; 2015 Apr; 48(3):856-62. PubMed ID: 25234740
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
Ellard S; Colclough K
Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
[TBL] [Abstract][Full Text] [Related]
25. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
Karlsson E; Shaat N; Groop L
Diabet Med; 2008 Jul; 25(7):788-91. PubMed ID: 18513302
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Retinopathy in Adult Patients with GCK-MODY and HNF1A-MODY.
Szopa M; Wolkow J; Matejko B; Skupien J; Klupa T; Wybrańska I; Trznadel-Morawska I; Kiec-Wilk B; Borowiec M; Malecki MT
Exp Clin Endocrinol Diabetes; 2015 Oct; 123(9):524-8. PubMed ID: 26240958
[TBL] [Abstract][Full Text] [Related]
27. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity-onset diabetes of the young? The case of autoimmunity-associated destruction of pancreatic β-cells in a family of HNF1A-MODY subjects.
Urbanová J; Rypáčková B; Kučera P; Anděl M; Heneberg P
Int Arch Allergy Immunol; 2013; 161(3):279-84. PubMed ID: 23548576
[TBL] [Abstract][Full Text] [Related]
28. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
[TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic protein 3 controls insulin gene expression and is down-regulated in INS-1 cells inducibly expressing a hepatocyte nuclear factor 1A-maturity-onset diabetes of the young mutation.
Bonner C; Farrelly AM; Concannon CG; Dussmann H; Baquié M; Virard I; Wobser H; Kögel D; Wollheim CB; Rupnik M; Byrne MM; König HG; Prehn JH
J Biol Chem; 2011 Jul; 286(29):25719-28. PubMed ID: 21628466
[TBL] [Abstract][Full Text] [Related]
30. The Mutation Spectrum of Maturity Onset Diabetes of the Young (MODY)-Associated Genes among Western Siberia Patients.
Ivanoshchuk DE; Shakhtshneider EV; Rymar OD; Ovsyannikova AK; Mikhailova SV; Fishman VS; Valeev ES; Orlov PS; Voevoda MI
J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33477506
[TBL] [Abstract][Full Text] [Related]
31. Incidence of
Matsha TE; Raghubeer S; Tshivhase AM; Davids SFG; Hon GM; Bjørkhaug L; Erasmus RT
Appl Clin Genet; 2020; 13():209-219. PubMed ID: 33363396
[TBL] [Abstract][Full Text] [Related]
32. Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
Ekholm E; Shaat N; Holst JJ
Acta Diabetol; 2012 Oct; 49(5):349-54. PubMed ID: 21761282
[TBL] [Abstract][Full Text] [Related]
33. Three novel mutations in MODY and its phenotype in three different Czech families.
Bazalová Z; Rypácková B; Broz J; Brunerová L; Polák J; Rusavý Z; Treslová L; Andel M
Diabetes Res Clin Pract; 2010 May; 88(2):132-8. PubMed ID: 20132997
[TBL] [Abstract][Full Text] [Related]
34. Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical data.
Giuffrida FMA; Moises RS; Weinert LS; Calliari LE; Manna TD; Dotto RP; Franco LF; Caetano LA; Teles MG; Lima RA; Alves C; Dib SA; Silveiro SP; Dias-da-Silva MR; Reis AF;
Diabetes Res Clin Pract; 2017 Jan; 123():134-142. PubMed ID: 28012402
[TBL] [Abstract][Full Text] [Related]
35. Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY).
McKinney JL; Cao H; Robinson JF; Metzger DL; Cummings E; Riddell DC; Sanderson SR; Pacaud D; Ho J; Hegele RA
Clin Invest Med; 2004 Jun; 27(3):135-41. PubMed ID: 15305805
[TBL] [Abstract][Full Text] [Related]
36. Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature.
Fu J; Wang T; Zhai X; Xiao X
Endocrine; 2020 Mar; 67(3):544-551. PubMed ID: 31754975
[TBL] [Abstract][Full Text] [Related]
37. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2).
Spégel P; Ekholm E; Tuomi T; Groop L; Mulder H; Filipsson K
Diabetes; 2013 Feb; 62(2):653-61. PubMed ID: 23139355
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study).
Eide SA; Raeder H; Johansson S; Midthjell K; Søvik O; Njølstad PR; Molven A
Diabet Med; 2008 Jul; 25(7):775-81. PubMed ID: 18513305
[TBL] [Abstract][Full Text] [Related]
39. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.
Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG
Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077
[TBL] [Abstract][Full Text] [Related]
40. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY).
Cao H; Shorey S; Robinson J; Metzger DL; Stewart L; Cummings E; Hegele RA
Hum Mutat; 2002 Dec; 20(6):478-9. PubMed ID: 12442280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
